中文 | English
Return
Total: 12 , 1/2
Show Home Prev Next End page: GO
MeSH:(APOBEC-3G Deaminase)

1.Association between APOBEC3G polymorphisms and susceptibility to chronic hepatitis B.

Zhiyi YOU ; Fuyuan ZHOU ; Xionghu WANG ; Chuming CHEN ; Junhua ZHOU ; Dejian ZHAO ; Guifang HU

Journal of Southern Medical University 2013;33(5):769-771

2.Enhanced protein production of Vif and APOBEC3G by HIV-1 Vpr.

Lin LI ; Dong LIANG ; Jing-yun LI ; Yu-qi ZHAO

Chinese Journal of Experimental and Clinical Virology 2008;22(1):39-41

3.The associations between polymorphisms of APOBEC3G and different outcomes of persistent HBV infection.

Di TIAN ; Zheng ZENG ; Guo-bao TIAN ; Jian-jun CUI

Chinese Journal of Hepatology 2008;16(7):481-486

4.Progress in the study of HIV-1 Vif and related inhibitors.

Zhen-Yu LI ; Peng ZHAN ; Xin-Yong LIU

Acta Pharmaceutica Sinica 2010;45(6):684-693

5.Inhibition of hepatitis B and duck hepatitis B virus replication by APOBEC3G.

Yan-Chang LEI ; Tao MA ; You-Hua HAO ; Zheng-Mao ZHANG ; Yong-Jun TIAN ; Bao-Ju WANG ; Dong-Liang YANG

Chinese Journal of Hepatology 2006;14(10):738-741

6.Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1.

Bo FAN ; Shan CEN ; Jian-dong JIANG

Acta Pharmaceutica Sinica 2008;43(7):678-682

7.Research methods of anti-HIV-1 inhibitors targeting at Vif-APOBEC3G axis.

Xinhua QIAO ; Wenjun ZHANG ; Zelin LI ; Yi ZENG

China Journal of Chinese Materia Medica 2011;36(6):806-809

8.Recent advances in the study of mechanism of APOBEC3G against virus.

Yan-Ping ZHU ; Jian-Dong JIANG ; Zong-Gen PENG

Acta Pharmaceutica Sinica 2014;49(1):30-36

9.Inhibitory effect of a HBV vector plasmid expressing A3C on HBV replication.

Dong LI ; Yu-ming WANG

Journal of Southern Medical University 2009;29(10):2044-2050

10.Tactics used by HIV-1 to evade host innate, adaptive, and intrinsic immunities.

Lu LU ; Fei YU ; Lan-Ying DU ; Wei XU ; Shi-Bo JIANG

Chinese Medical Journal 2013;126(12):2374-2379

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 12 , 1/2 Show Home Prev Next End page: GO